MustGrow Biologics提议约200万美元私募

2024-12-11 20:27

MustGrow Biologics (TSXV:MGRO:CA) (OTCQB:MGROF) has proposed a non-brokered private placement of ~2K units, priced at $1K per unit, to raise gross proceeds of ~$2M.
The offering includes an option to increase the size of the private placement by $1M.
The agricultural biotechnology company intends to close the private placement on or about January 10, 2025.
Each unit comprises of $1K principal amount of unsecured convertible debentures and 666 common share purchase warrants.
Each debenture may, at the option of the holder, be converted into common shares at $1.50 per share or paid in cash 60 months following the closing date.
Each warrant can be exercisable by the holder thereof to acquire one share at $1.90 per share.
The debentures will accrue interest at a rate of 8% per annum. Accrued interest shall be payable semi-annually in cash.
The proceeds are intended to be used for inventory production for TerraSante, working capital and general corporate purposes.
Source: Press Release

More on MustGrow Biologics